PRESS RELEASE published on 06/01/2023 at 10:00, 1 year 11 months ago Apogenix AG: Apogenix’ new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model
PRESS RELEASE published on 03/27/2023 at 10:00, 2 years 1 month ago Apogenix’ Partner CANbridge Announces 67 % Five-Year Overall Survival Rate Compared to 8.2 % in Institutional Database With Asunercept Plus Standard of Care in Newly Diagnosed Glioblastoma Multiforme
Published on 05/24/2025 at 02:00, 1 day 2 hours ago Battery X Metals Advances Development of Next-Generation Battery Rebalancing Technology for the #2 Out-of-Warranty Electric Vehicle in the United States
Published on 05/24/2025 at 00:00, 1 day 4 hours ago Forward Water Technologies Corp. Announces Change of Auditor
Published on 05/23/2025 at 23:10, 1 day 5 hours ago urban-gro, Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1)
Published on 05/23/2025 at 22:05, 1 day 6 hours ago Moderna Files FDA Application for the LP.8.1 Targeting COVID-19 Vaccine
Published on 05/23/2025 at 20:45, 1 day 7 hours ago New to The Street Launches ETF Leaders: Opportunities To Consider(TM)
Published on 05/24/2025 at 17:41, 10 hours 28 minutes ago R-LOGITECH S.A. agrees an amendment and restatement of €20 million loan facility dated 22 July 2024
Published on 05/24/2025 at 11:31, 16 hours 39 minutes ago Annual General Meeting of Curatis Holding AG approved all proposals of the Board of Directors
Published on 05/24/2025 at 10:00, 18 hours 10 minutes ago Hong Kong and Middle East: Partnering for Success
Published on 05/23/2025 at 19:15, 1 day 8 hours ago Walls & Futures REIT PLC: Notice of General Meeting
Published on 05/23/2025 at 19:04, 1 day 9 hours ago Shareholders of Basler AG approve agenda items of today's Annual General Meeting
Published on 05/23/2025 at 19:00, 1 day 9 hours ago Paulic meunerie - notification de mise a disposition RFA 2024
Published on 05/23/2025 at 17:51, 1 day 10 hours ago Finalisation de la 1ère tranche du programme de rachat d'action
Published on 05/23/2025 at 17:51, 1 day 10 hours ago Completion of the 1st tranche of the share buyback program
Published on 05/23/2025 at 08:00, 1 day 20 hours ago KLARSEN : Initiation de couverture de la valeur par CHAMPEIL SA
Published on 05/23/2025 at 07:30, 1 day 20 hours ago Vif succès de l’augmentation de capital de NFL Biosciences avec une levée plafonnée à 3 millions d’euros
